Inimmune picks up $22m Series A

Missoula, Montana-based Inimmune, a developer of immune therapies and components for more effective vaccines, has raised $22 million in Series A funding.

Missoula, Montana-based Inimmune, a developer of immune therapies and components for more effective vaccines, has raised $22 million in Series A funding. Two Bear Capital led the round. In addition to the funding, Two Bear Capital founder and Managing Partner Michael Goguen will join Inimmune’s board of directors.

Source: Press Release